These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Acrodermatitis continua of Hallopeau successfully treated with bimekizumab: A case report. Cirone KD; Lovegrove FE SAGE Open Med Case Rep; 2023; 11():2050313X231160937. PubMed ID: 36968989 [TBL] [Abstract][Full Text] [Related]
25. An infant with acrodermatitis continua of Hallopeau: successful treatment with thalidomide and UVB therapy. Kiszewski AE; De Villa D; Scheibel I; Ricachnevsky N Pediatr Dermatol; 2009; 26(1):105-6. PubMed ID: 19250426 [TBL] [Abstract][Full Text] [Related]
26. Successful treatment of acrodermatitis continua of Hallopeau with tildrakizumab: A case report. Nguyen A; D'Aguanno K; Ridha Z; Tsoukas A; Netchiporouk E SAGE Open Med Case Rep; 2023; 11():2050313X231180775. PubMed ID: 37359284 [TBL] [Abstract][Full Text] [Related]
27. Pemphigus vegetans of Hallopeau masquerading as acrodermatitis continua suppurativa. Jindal R; Chauhan P; Raturi S Indian J Dermatol Venereol Leprol; 2021 [SEASON]; 87(4):560-562. PubMed ID: 34114425 [No Abstract] [Full Text] [Related]
28. Case of acrodermatitis continua of Hallopeau following psoriasis with atypical clinical presentation. Iijima S; Okazaki Y; Watanabe S; Maruyama Y J Dermatol; 2014 Nov; 41(11):1006-8. PubMed ID: 25346303 [TBL] [Abstract][Full Text] [Related]
30. Rapid and sustained response to apremilast in a patient with long-standing acrodermatitis continua of Hallopeau. Fusta-Novell X; Esquius M; Creus-Vila L Dermatol Online J; 2022 Dec; 28(6):. PubMed ID: 36809102 [No Abstract] [Full Text] [Related]
31. Acrodermatitis continua of Hallopeau: was it an outcome of a surgical trauma or initially misdiagnosed as onychomycosis? Sahin MT; Oztürkcan S; Türel A; Kandiloğlu AR J Eur Acad Dermatol Venereol; 2003 Mar; 17(2):236-8. PubMed ID: 12705767 [No Abstract] [Full Text] [Related]
32. A case of pediatric acrodermatitis continua of Hallopeau successfully treated with adalimumab biosimilar. Megna M; Fabbrocini G; Costa C; Ferrillo M Dermatol Ther; 2020 May; 33(3):e13327. PubMed ID: 32220123 [No Abstract] [Full Text] [Related]
33. Treatment of acrodermatitis continua of hallopeau with ixekizumab. Miller AC; Holland TE; Cohen DJ J Dermatolog Treat; 2021 Feb; 32(1):117-119. PubMed ID: 31184530 [TBL] [Abstract][Full Text] [Related]
34. [Acrodermatitis continua of Hallopeau and psoriatic arthritis: A case report]. García C; Arellano J; Vera V; Corredoira Y Medwave; 2020 Sep; 20(8):e8021. PubMed ID: 32956338 [TBL] [Abstract][Full Text] [Related]
35. Local injection of micro-dose guselkumab for acrodermatitis continua of Hallopeau after failure of systemic ixekizumab treatment. Wang Y; Zhou C; Hou Y; Diao Z; Chen D; Yin Z Int J Dermatol; 2024 Apr; 63(4):547-548. PubMed ID: 38228398 [No Abstract] [Full Text] [Related]
36. Acrodermatitis continua of hallopeau successfully treated with adalimumab. Sopkovich JA; Anetakis Poulos G; Wong HK J Clin Aesthet Dermatol; 2012 Feb; 5(2):60-2. PubMed ID: 22468174 [TBL] [Abstract][Full Text] [Related]
37. Treatment of Recalcitrant Acrodermatitis Continua of Hallopeau With Brodalumab. Milani-Nejad N; Kaffenberger J J Drugs Dermatol; 2019 Oct; 18(10):1047. PubMed ID: 31603633 [TBL] [Abstract][Full Text] [Related]